Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenues:
Contract revenue	$ 1,930,533	$ 3,215,639
Grant revenue	428,914	1,414,277
Total revenues	2,359,447	4,629,916
Cost of revenues	(1,820,949)	(3,567,415)
Gross profit	538,498	1,062,501
Operating expenses:
Research and development	10,145,778	8,122,610
General and administrative	3,979,227	3,480,912
Research and development expense - milestone	5,000,000
Total operating expenses	19,125,005	11,603,522
Loss from operations	(18,586,507)	(10,541,021)
Other income (expense):
Foreign currency transaction loss	(23,385)	(7,809)
Interest income (expense)	(10,882)	148,968
Research and development incentives	95,359	433,594
Net loss before income taxes	(18,525,415)	(9,966,268)
Income tax benefit	836,893	610,676
Net loss	$ (17,688,522)	$ (9,355,592)
Basic and diluted net loss per share (in Dollars per share)	$ (0.64)	$ (0.48)
Basic and diluted weighted average common shares outstanding (in Shares)	27,486,949	19,376,508